Endothelial progenitor cell mobilization and platelet microparticle release are influenced by clopidogrel plasma levels in stable coronary artery disease

Circulation Journal

Volumn 76, Issue 3, 2012, Pages 729-736

  França, Carolina N ^a   Pinheiro, Luiz F M ^a   Izar, Maria C O ^a,b   Brunialti, Milena K C ^a   Salomão, Reinaldo ^a   Bianco, Henrique T ^a   Kasmas, Soraia H ^a   Barbosa, Simone P ^a   de Nucci, Gilberto ^c   Fonseca, Francisco A H ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b National Institute of Complex Fluids   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Clopidogrel; Endothelial progenitor cells; Pharmacokinetics; Platelets; Statin

Indexed keywords

ALANINE AMINOTRANSFERASE; ATORVASTATIN; CD133 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD42 ANTIGEN; CD51 ANTIGEN; CHOLESTEROL; CLOPIDOGREL; CREATINE KINASE; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYMPHOCYTE ANTIGEN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; ENDOTHELIAL MICROPARTICLE; ENDOTHELIAL PROGENITOR CELL; FEMALE; HUMAN; MALE; MAXIMUM PLASMA CONCENTRATION; OPEN STUDY; PLASMA CONCENTRATION-TIME CURVE; PLATELET MICROPARTICLE; PROSPECTIVE STUDY; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADULT; AGED; BLOOD PLATELETS; CELL MOVEMENT; CELL-DERIVED MICROPARTICLES; CORONARY ARTERY DISEASE; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROTECTIVE AGENTS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; STEM CELLS; TICLOPIDINE;

EID: 84857615158     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-1145     Document Type: Article

References (39)

1. Wojakowski W, Kucia M, Kaźmierski M, Ratajczak MZ, Tendera M. Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: Relevant reparatory mechanism? Heart 2008; 94: 27-33.
2. Fadini GP, Maruyama S, Ozaki T, Taguchi A, Meigs J, Dimmeler S, et al. Circulating progenitor cell count for cardiovascular risk stratification: A pooled analysis. PLoS One 2010; 5: e11488.
3. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999-1007.
4. Fadini GP, Agostini C, Sartore S, Avogaro A. Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis 2007; 194: 46-54.
5. Schwartzenberg S, Afek A, Charach G, Rubinstein A, Ben-Shoshan Y, Kissil S, et al. Comparative analysis of the predictive power of different endothelial progenitor cell phenotypes on cardiovascular outcome. World J Cardiol 2010; 2: 299-304.
6. Lee LC, Chen CS, Choong PF, Low A, Tan HC, Poh KK. Timedependent dynamic mobilization of circulating progenitor cells during percutaneous coronary intervention in diabetics. Int J Cardiol 2010; 142: 199-201.
7. Park JA, Kwon YG. Could circulating progenitor cell count be a barometer for coronary artery disease progression? Circ J 2010; 74: 1804-1805.
8. Tushuizen ME, Diamant M, Sturk A, Nieuwland R. Cell-derived microparticles in the pathogenesis of cardiovascular disease: Friend or foe? Arterioscler Thromb Vasc Biol 2011; 31: 4-9.
9. Morel O, Jesel L, Freyssinet JM, Toti F. Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol 2011; 31: 15-26.
10. Dignat-George F, Boulanger CH. The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol 2011; 31: 27-33.
11. Sinning JM, Losch J, Walenta K, Böhm M, Nickenig G, Werner N. Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J 2010; 32: 2034-2041.
12. Leone AM, Rutella S, Giannico MB, Perfetti M, Zaccone V, Brugaletta S, et al. Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial. Int J Cardiol 2008; 130: 457-462.
13. Schwartzenberg S, Deutsch V, Maysel-Auslender S, Kissil S, Keren G, George J. Circulating apoptotic progenitor cells: A novel biomarker in patients with acute coronary syndromes. Arterioscler Thromb Vasc Biol 2007; 27: e27-e31.
14. Wojakowski W, Tendera M. Mobilization of bone marrow-derived progenitor cells in acute coronary syndromes. Folia Histochem Cytobiol 2005; 43: 229-232.
15. Lau, WC, Waskell LA, Watkins PB, Neer CJ, Horowitz K, Hopp AS, et al. Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: A new drug-drug interaction. Circulation 2003; 107: 32-37.
16. Hamilos M, Muller O, Ntalianis A, Trana C, Bartunek J, Sarno G, et al. Relationship between peripheral arterial reactive hyperemia and residual platelet reactivity after 600 mg clopidogrel. J Thromb Thrombolysis 2011; 32: 64-71.
17. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 2003; 107: 149-158.
18. Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001. Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005; 46: e1-e82.
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
20. da Silva EF, Fonseca FA, França CN, Ferreira PR, Izar MC, Salomão R, et al. Imbalance between endothelial progenitor cells and microparticles in HIV-infected patients naïve for antiretroviral therapy. AIDS 2011; 25: 1595-1601.
21. Robinson A, Hillis J, Neal C, Leary AC. The validation of a bioanalytical method for the determination of clopidogrel in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 848: 344-354.
22. He BX, Shi L, Qiu J, Zeng XH, Tao L, Li R, et al. Quantitative determination of atorvastatin and ortho-hydroxy atorvastatin in human plasma by liquid chromatography tandem mass spectrometry and pharmacokinetic evaluation. Methods Find Exp Clin Pharmacol 2010; 32: 481-487.
23. Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Schömig A, et al. Platelet reactivity after clopidogrel treatment assessed with point-ofcare analysis and early drug-stent thrombosis. J Am Coll Cardiol 2009; 53: 849-856.
24. Morrison A, Hornsey VS, Prowse CV, Macgregor IR. Use of the DiaMed Impact R to test platelet function in stored platelet concentrates. Vox Sang 2007; 93: 166-172.
25. Ryu JH, Kim SJ. Clopidogrel effectively suppresses endothelial microparticle generation induced by indoxyl sulfate via inhibition of the p38 mitogen-activated protein kinase pathway. Blood Purif 2011; 32: 186-194.
26. Chironi GN, Boulanger CM, Simon A, Dignat-George F, Freyssinet JM, Tedgui A. Endothelial microparticles in diseases. Cell Tissue Res 2009; 335: 143-151.
27. Nozaki T, Sugiyama S, Koga H, Sugamura K, Ohba K, Matsuzawa Y, et al. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. J Am Coll Cardiol 2009; 54: 601-608.
28. Rautou PE, Vion AC, Amabile N, Chironi G, Simon A, Tedgui A, et al. Microparticles, vascular function, and atherothrombosis. Circ Res 2011; 109: 593-606.
29. Siljander P, Carpen O, Lassila R. Platelet-derived microparticles associate with fibrin during thrombosis. Blood 1996; 87: 4651-4663.
30. Ramacciotti E, Hawley AE, Farris DM, Ballard NE, Wrobleski SK, Myers DD Jr, et al. Leukocyte-and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis. Thromb Haemost 2009; 101: 748-754.
31. Martinez MC, Andriantsitohaina R. Microparticles in angiogenesis: Therapeutic potential. Circ Res 2011; 109: 110-119.
32. Cholesterol Treatment Trialists' (CTT) Collaboration; Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010; 376: 1670-1681.
33. Lotfi A, Schweiger MJ, Giugliano GR, Murphy SA, Cannon CP; TIMI 22 Investigators. High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22). Am Heart J 2008; 155: 954-958.
34. Serebruany VL, Midei MG, Malinin AI, Oshrine BR, Lowry DR, Sane DC, et al. Absence of interaction between atorvastatin or other statins and clopidogrel: Results from the interaction study. Arch Intern Med 2004; 164: 2051-2057.
35. Wenaweser P, Windecker S, Billinger M, Cook S, Togni M, Meier B, et al. Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis. Am J Cardiol 2007; 99: 353-356.
36. Farid NA, Small DS, Payne CD, Jakubowski JA, Brandt JT, Li YG, et al. Effect of atorvastatin on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in healthy subjects. Pharmacotherapy 2008; 28: 1483-1494.
37. Malmström RE, Östergren J, Jorgensen L, Hjemdahl P; CASTOR investigators. Influence of statin treatment on platelet inhibition by clopidogrel: A randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment. J Intern Med 2009; 266: 457-466.
38. Turan RG, Turan CH, Bozdag-Turan I, Ortak J, Akin I, Kische S, et al. Impaired mobilization of CD133+ bone marrow-derived circulating progenitor cells with an increased number of diseased coronary arteries in ischemic heart disease patients with diabetes. Circ J 2011; 75: 2635-2641.
39. Zhou Q, Liao JK. Pleiotropic effects of statins: Basic research and clinical perspectives. Circ J 2010; 74: 818-826.